Small extracellular vesicles proteome reveals persistent inflammatory and coagulopathic dysregulation in long-COVID

Background

Post-acute sequelae of SARS-CoV-2 (PASC) or Long-COVID affects millions and remains mechanistically undefined due to its heterogeneous clinical presentation. Identifying robust biological signatures is essential for understanding disease mechanisms and improving diagnosis. Here, we investigated the protein cargo of plasma-derived small extracellular vesicles (SEVs) from PASC-positive and PASC-negative individuals to identify EV-linked biomarkers of Long-COVID.

Methods

SEVs were isolated from EDTA plasma of PASC-positive (n=20) and PASC-negative (n=11) individuals using size-exclusion chromatography. SEV protein cargo was profiled across more than 5400 proteins using the Olink Explore HT platform.

Results

PASC-positive patients commonly reported fatigue, shortness of breath, brain fog, sleep disruption, and mood changes. Proteomic analysis revealed 269 significantly dysregulated proteins, including 84 upregulated and 21 downregulated, with a fold change >2 in PASC. These differentially altered proteins were enriched in pathways related to coagulation, inflammation, apoptosis, fibrosis, extracellular matrix remodeling, mitochondrial dynamics, and immune activation. PASC-positive SEVs showed persistent increases in FN1, HCF-H, HGF, and IL-17RA, proteins previously dysregulated in acute COVID-19. These markers showed greater differences in SEVs than in matched plasma, particularly HGF and IL-17RA, which were significantly altered in SEVs but not in plasma.

Conclusion

Proteomic alterations in SEVs from PASC patients highlight the inflammatory, thrombotic, and neurobiological dysregulation, underscoring the potential of SEVs as biomarkers and mechanistic drivers of long COVID.